Non-valvular atrial fibrillation accounts for 13–26% of acute ischaemic strokes.1 Direct oral anticoagulants (DOACs) are ...

Post-therapy imaging and dosimetry significantly enhance patient management, empowering clinicians to make more informed, ...

In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to ...

OS Therapies Submits Request for Regenerative Medicine Advanced Therapy (RMAT) Designation to U.S. FDA for OST-HER2 in the Prevention of Metastases in Recurrent, Fully-Resected, ...

Claudin-18 isoform 2 (CLDN18.2) has emerged as a promising therapeutic target in gastric or gastro-oesophageal junction cancer. Satricabtagene autoleucel (satri-cel; also known as CT041), an ...

OS Therapies Inc., a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today announced it has submitted a request for Regenerative Medicine Advanced Therapy ...

Baby saved by gene-editing therapy 'graduates' from hospital, goes home. KJ Muldoon was diagnosed with a rare, deadly genetic disease after he was born. By Sony Salzman. June 4, 2025, 11:09 AM.

ALSO SEE: Pioneering gene editing therapy could give 5-year-old with rare, fatal disorder a new chance at life The nearly 10-month-old was released from the hospital on Tuesday, as caregivers ...

The ACG has released new clinical guidelines for the management of ulcerative colitis and Crohn’s disease in adult patients.The guidelines, published in The American Journal of Gastroenterology ...

Other cell therapy developers that presented at ASCO 2025 were Kite Pharma and Immatics. The latter’s cell therapy PRAME has been linked to a 56% objective response rate (ORR) among 32 heavily ...

Introduction. Gastric cancer (GC) is the fifth most prevalent malignancy worldwide (), with a generally poor prognosis ().Following the landmark MAGIC trial (3–5), neoadjuvant therapy (NAT) has been ...